Market Research Industry Reports

Morphotek Inc - Pharmaceuticals and Healthcare - Deals and Alliances Profile

  • DESCRIPTION
  • TABLE OF CONTENTS
  • RELATED REPORTS
  • SAMPLE REQUEST
  • REVIEWS
Summary

Morphotek Inc (Morphotek), a subsidiary of Eisai Inc, is a clinical-stage biotechnology company that develops monoclonal antibodies, antibody drug conjugates, and bispecific antibodies to treat cancer, inflammatory and infectious diseases. Its pipeline product portfolio includes farletuzumab, a humanized IgG1 antibody targeting folate receptor alpha (FRA) for the treatment of ovarian and lung cancers; and amatuximab, a chimeric, IgG1 antibody that targets a cell-surface glycoprotein, mesothelin for treating mesothelioma. Morphotek also provides ontuxizumab targets cell-surface protein, endosialin for the treatment of cancers; gimsilumab against rheumatoid arthritis (RA); MORAb-202, an antibody drug conjugate (ADC) for metastatic breast cancer; and MORAb-048, MORAb-050 and MORAb-066 targeting tissue factor (TF) expressing malignancies. It offers services such as drug discovery and development, GLP and GMP production, antibodies investigation, antibody and protein engineering technologies, and others. The company works in partnership with other biotech companies, research organizations, and academic centers for discovery and development of its pipeline products. Morphotek is headquartered in Exton, Pennsylvania, the US.

Morphotek Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

it derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.



List of Tables 4
List of Figures 4
Morphotek Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Morphotek Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Morphotek Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Morphotek Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Morphotek Inc, Medical Devices Deals, 2012 to YTD 2018 9
Morphotek Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Morphotek Inc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Morphotek Enters into Research Agreement with Rockefeller University 11
Morphotek Enters into Agreement with Johns Hopkins University School of Medicine 12
Morphotek Enters into Research Agreement with Fox Chase Cancer Center 13
Morphotek Enters into Agreement with Areva Med 14
Morphotek Enters into Agreement with Mayo Clinic 15
Morphotek Enters into Research Agreement with University of Wisconsin Madison 16
Morphotek Enters into R&D Agreement with Targeted Alpha Therapy 17
Stealth Biologics Enters into Co-Development Agreement with Morphotek 18
Sorrento Therapeutics Enters into Co-Development Agreement with Morphotek 19
Licensing Agreements 20
Morphotek Enters into Licensing Agreement with Bliss Biopharma 20
Morphotek Enters into Licensing Agreement with Eurofarma Laboratorios 21
Blaze Bioscience Enters into Licensing Agreement with Morphotek 22
Morphotek Inc - Key Competitors 23
Morphotek Inc - Key Employees 24
Morphotek Inc - Locations And Subsidiaries 25
Head Office 25
Recent Developments 26
Product News 26
12/07/2017: Morphotek To Present Its Proprietary RESPECT Antibody-Drug Conjugate (ADC) Technology At The Upcoming Antibody Engineering & Therapeutics Conference In San Diego 26
11/13/2017: Morphotek To Present Its Proprietary RESPECT Antibody Drug Conjugate (ADC) Technology At The Upcoming 9th Annual PEGS Europe In Lisbon 27
09/22/2017: Eisai Presents Latest Non-Clinical Data On Its First Antibody-Drug Conjugate MORAb-202 At 8th Annual World ADC 28
Clinical Trials 29
Dec 04, 2017: Morphotek Announces Initiation Of Phase 1 Study Of Next-Generation Farletuzumab Antibody-Drug Conjugate MORAb-202 In Solid Tumors With Folate Receptor Alpha Expression 29
Sep 19, 2017: Morphotek To Present Preclinical Data On Antibody-Drug Conjugate MORAb-202 At The Upcoming 8th Annual World ADC In San Diego 30
Appendix 31
Methodology 31
About GlobalData 31
Contact Us 31
Disclaimer 31

List Of Tables


Morphotek Inc, Pharmaceuticals & Healthcare, Key Facts 2
Morphotek Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Morphotek Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Morphotek Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Morphotek Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Morphotek Inc, Medical Devices Deals, 2012 to YTD 2018 9
Morphotek Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Morphotek Enters into Research Agreement with Rockefeller University 11
Morphotek Enters into Agreement with Johns Hopkins University School of Medicine 12
Morphotek Enters into Research Agreement with Fox Chase Cancer Center 13
Morphotek Enters into Agreement with Areva Med 14
Morphotek Enters into Agreement with Mayo Clinic 15
Morphotek Enters into Research Agreement with University of Wisconsin Madison 16
Morphotek Enters into R&D Agreement with Targeted Alpha Therapy 17
Stealth Biologics Enters into Co-Development Agreement with Morphotek 18
Sorrento Therapeutics Enters into Co-Development Agreement with Morphotek 19
Morphotek Enters into Licensing Agreement with Bliss Biopharma 20
Morphotek Enters into Licensing Agreement with Eurofarma Laboratorios 21
Blaze Bioscience Enters into Licensing Agreement with Morphotek 22
Morphotek Inc, Key Competitors 23
Morphotek Inc, Key Employees 24

List Of Figures


Morphotek Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Morphotek Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Morphotek Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Morphotek Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Morphotek Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Morphotek Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Morphotek Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Morphotek Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Morphotek Inc, Medical Devices Deals, 2012 to YTD 2018 9

Morphotek Inc - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Morphotek Inc (Morphotek), a subsidiary of Eisai Inc, is a clinical-stage biotechnology company that develops monoclonal antibodies, antibody drug conjugates, and bispecific antibodies to treat cancer, inflammatory and infectious diseases.

USD 250View Report

Morphotek Inc - Mergers and Acquisitions (MandA), Partnerships and Alliances and Investment Report

Morphotek Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment ReportThe Morphotek Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports

USD 350View Report

Pear Therapeutics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Pear Therapeutics Inc (Pear Therapeutics) develops software-based prescription digital therapeutics for the treatment of severe medical conditions and diseases. Its product pipeline includes reSET-O for treating opioid use disorder (OUD)

USD 250View Report

Aspire Health Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Aspire Health Inc (Aspire) is a healthcare company which operates a network of outpatient palliative care practices providing medical care for patients with relief from the symptoms, pain, and stress

USD 250View Report

Your are not allow to send sample request
Fill The Form For Sample Request
Full Name :*
Bussiness Email: *
Email: *
Country :*
Contact No.*
Alternate No.
Note.:*Kindly provide us with your company id and get the sample reports at the earliest.
There is no Reviews available

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

  • PDF    USD 250
  • Site Licence    USD 500
  • Enterprise Wide Licence    USD 750
$ 250

Reports Details

Published Date : Sep 2018
No. of Pages :31
Country :United States of America
Category :Company Profiles
Publisher :GlobalData
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

  • fb
  • twitter
  • pinterest
  • linckedin
  • rss
  • youtube